Rockefeller Capital Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.02M | Sell |
17,995
-1,438
| -7% | -$608K | 0.01% | 836 |
|
|
2026
Q1 | $9.2M | Buy |
19,433
+476
| +3% | +$240K | 0.02% | 704 |
|
|
2025
Q4 | $8.85M | Buy |
18,957
+2,876
| +18% | +$1.34M | 0.02% | 699 |
|
|
2025
Q3 | $6.85M | Sell |
16,081
-4,481
| -22% | -$1.74M | 0.01% | 732 |
|
|
2025
Q2 | $7.88M | Buy |
20,562
+5,880
| +40% | +$2.12M | 0.02% | 679 |
|
|
2025
Q1 | $5.07M | Sell |
14,682
-6,762
| -32% | -$2.17M | 0.01% | 734 |
|
|
2024
Q4 | $6.44M | Sell |
21,444
-1,646
| -7% | -$575K | 0.02% | 654 |
|
|
2024
Q3 | $9.38M | Buy |
23,090
+440
| +2% | +$161K | 0.03% | 563 |
|
|
2024
Q2 | $7.28M | Buy |
22,650
+2,371
| +12% | +$770K | 0.02% | 595 |
|
|
2024
Q1 | $6.76M | Buy |
20,279
+3,654
| +22% | +$1.12M | 0.02% | 606 |
|
|
2023
Q4 | $4.5M | Buy |
16,625
+4,106
| +33% | +$1.01M | 0.02% | 665 |
|
|
2023
Q3 | $3.08M | Buy |
12,519
+403
| +3% | +$110K | 0.01% | 710 |
|
|
2023
Q2 | $3.68M | Sell |
12,116
-2,446
| -17% | -$680K | 0.01% | 670 |
|
|
2023
Q1 | $3.84M | Buy |
14,562
+205
| +1% | +$52.1K | 0.02% | 629 |
|
|
2022
Q4 | $3.44M | Buy |
14,357
+1,999
| +16% | +$448K | 0.02% | 605 |
|
|
2022
Q3 | $2.27M | Buy |
12,358
+2,781
| +29% | +$554K | 0.01% | 722 |
|
|
2022
Q2 | $1.61M | Buy |
9,577
+989
| +12% | +$212K | 0.01% | 832 |
|
|
2022
Q1 | $2.15M | Buy |
8,588
+1,174
| +16% | +$295K | 0.01% | 779 |
|
|
2021
Q4 | $1.91M | Buy |
7,414
+513
| +7% | +$126K | 0.01% | 809 |
|
|
2021
Q3 | $1.67M | Buy |
6,901
+572
| +9% | +$140K | 0.01% | 816 |
|
|
2021
Q2 | $1.31M | Buy |
6,329
+1,190
| +23% | +$243K | 0.01% | 835 |
|
|
2021
Q1 | $967K | Sell |
5,139
-349
| -6% | -$61.5K | 0.01% | 792 |
|
|
2020
Q4 | $902K | Sell |
5,488
-1,472
| -21% | -$215K | 0.01% | 718 |
|
|
2020
Q3 | $867K | Buy |
6,960
+1,164
| +20% | +$144K | 0.01% | 635 |
|
|
2020
Q2 | $563K | Buy |
5,796
+3,877
| +202% | +$403K | 0.01% | 667 |
|
|
2020
Q1 | $172K | Buy |
1,919
+770
| +67% | +$99.7K | ﹤0.01% | 854 |
|
|
2019
Q4 | $170K | Buy |
1,149
+29
| +3% | +$3.89K | ﹤0.01% | 810 |
|
|
2019
Q3 | $135K | Buy |
1,120
+57
| +5% | +$7.37K | ﹤0.01% | 707 |
|
|
2019
Q2 | $144K | Sell |
1,063
-472
| -31% | -$59.7K | ﹤0.01% | 633 |
|
|
2019
Q1 | $200K | Buy |
1,535
+1,330
| +649% | +$179K | ﹤0.01% | 603 |
|
|
2018
Q4 | $26K | Hold |
205
| – | – | ﹤0.01% | 597 |
|
|
2018
Q3 | $29K | Hold |
205
| – | – | ﹤0.01% | 478 |
|
|
2018
Q2 | $21K | Buy |
+205
| New | +$20.7K | ﹤0.01% | 524 |
|
Other funds holding HCA
Rockefeller Capital Management's HCA Position: Q2 2026 in Review
Rockefeller Capital Management reduced its HCA Healthcare (HCA) stake by 7.4% in Q2 2026, selling an estimated $608K and leaving 17,995 shares worth $7.02M. The position accounts for 0.01% of the portfolio, ranked #836.
Rockefeller Capital Management first reported a position in HCA in Q2 2018 and has held it in 33 quarters since. The position peaked at $9.38M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Rockefeller Capital Management held 17,995 shares of HCA Healthcare worth $7.02M as of Q2 2026.
- Rockefeller Capital Management sold 1,438 HCA Healthcare shares in Q2 2026, an estimated $608K.
- HCA Healthcare made up 0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #836 holding.
- Rockefeller Capital Management first reported a position in HCA Healthcare in Q2 2018 and has held it in 33 quarters since.
- Rockefeller Capital Management's HCA Healthcare position peaked at $9.38M in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.